ROCKVILLE, Maryland, June 17 /PRNewswire/ --
Pinnacle Biologics, a private, full-service pharmaceutical and biotech solutions company, today announced it has entered into a logistic service agreement with Movianto, a German-based company. The agreement, which is scheduled to take effect immediately, grants Movianto certain logistics and distribution rights in several countries in Europe. Additional terms of the agreement were not disclosed.
"The agreement with Movianto represents another milestone in Pinnacle's infrastructure and further showcases our vast capability to assist large pharmaceutical and biotechnology companies in optimizing the international market potential of mature products without diversion of resources from core businesses," said Guillermo Herrera, chairman of the board of Pinnacle Biologics. "Additionally, the Pinnacle business model is optimal for small biotechnology that require a total solution from pre-launch to commercialization of products."
Conor Roche, managing director of the Movianto Group commented: "Movianto is extremely excited about expanding our service portfolio to meet Pinnacle's unique distribution and logistics requirements and to accelerate the commercialization of the Pinnacle business model in Europe."
About Pinnacle Biologics
Founded in 2007 by health care executives Guillermo Herrera, James Miller, and Viren Grover, Pinnacle Biologics is a premier international company that excels in assisting pharmaceutical and biotech companies that require a total solution in either launching products or maximizing/monetizing the value of products late in their life cycle. Pinnacle forms exclusive relationships with research-based pharmaceutical multi-national corporations and biotechnology companies to take products to the next level.
Pinnacle provides a full range of services including regulatory, sales, marketing, distribution (including billing and collections), pharmacovigilence, product safety, market research and administrative services.
About Movianto
Movianto provides the pharmaceutical, biotechnology and healthcare industry with innovative logistics and distribution solutions across Europe. Movianto's 400 international clients, including the world's ten largest pharmaceutical manufacturers, benefit from a broad range of pharmaceutical logistics services and the variety of distribution models at national, regional and European level. Movianto is a business unit of Celesio AG. For further information, please visit http://www.movianto.com
Web site: http://www.movianto.com
James R. Miller, President & CEO of Pinnacle Biologics, +1-240-372-4599
Comments